BioCentury
ARTICLE | Clinical News

Phenolamine mesylate formulation to give rapid bioavailability: Began Phase II trial in Germany in 200 men, with the end point to be erection sufficient for vag

May 22, 1995 7:00 AM UTC

Zonagen Inc. (ZONA), The Woodlands, Texas Product: Phenolamine mesylate formulation to give rapid bioavailability Indication: Male impotence Status: Began Phase II trial in Germany in 200 men, with th...